Skip to main content
Clinical Trials/NCT02096484
NCT02096484
Completed
Not Applicable

Group Metacognitive Therapy Versus Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Feasibility Study

University of Manchester1 site in 1 country40 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Generalized Anxiety Disorder
Sponsor
University of Manchester
Enrollment
40
Locations
1
Primary Endpoint
Hospital Anxiety and Depression Scale (HADS)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The study will examine the effectiveness of group metacognitive therapy in comparison with group meditation therapy, in patients with Generalised Anxiety Disorder. Individuals will be randomly assigned to either meditation or metacognitive therapy and undergo 8 group therapy sessions of their respective treatment condition.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
June 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Adrian Wells

Professor of Clinical & Experimental Psychopathology

University of Manchester

Eligibility Criteria

Inclusion Criteria

  • individual's score on the GAD-7 \& PHQ-9
  • individuals who meet the DSM-IV (Diagnostic and Statistical Manual) criteria for generalized anxiety disorder

Exclusion Criteria

  • Individuals with major depressive disorder
  • Individuals who report suicidality
  • Individuals with a brain injury or neurological insult
  • Individual who currently engage in substance abuse
  • Individuals with bipolar disorder
  • Individuals with psychotic symptoms
  • Individuals who cannot converse or read English

Outcomes

Primary Outcomes

Hospital Anxiety and Depression Scale (HADS)

Time Frame: Administered at pre treatment, mid treatment, post treatment, and 6 month follow up

Secondary Outcomes

  • CAS-I(Administered at pre treatment, mid treatment, post treatment, and 6 month follow up)
  • GAD-7(Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of anxiety.)
  • PHQ-9(Completed prior to week 1 of treatment.This will be administered prior to treatment as a screening measure for levels of depression.)

Study Sites (1)

Loading locations...

Similar Trials